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Prostaglandin proﬁling reveals a role for haematopoietic
prostaglandin D synthase in adipose tissue macrophage
polarisation in mice and humans
S Virtue1,8, M Masoodi2,3,8, BAM de Weijer4, M van Eijk5, CYL Mok1, M Eiden2,6, M Dale1, A Pirraco1, MJ Serlie4, JL Grifﬁn2,7
and A Vidal-Puig1
BACKGROUND/OBJECTIVES: Obesity has been associated with both changes in adipose tissue lipid metabolism and inﬂammation.
A key class of lipid-derived signalling molecules involved in inﬂammation are the prostaglandins. In this study, we aimed to
determine how obesity affects the levels of prostaglandins within white adipose tissue (WAT) and determine which cells within
adipose tissue produce them. To avoid the effects of cellular stress on prostaglandin levels, we developed a multivariate statistical
approach in which metabolite concentrations and transcriptomic data were integrated, allowing the assignment of metabolites to
cell types.
SUBJECTS/METHODS: Eicosanoids were measured by liquid chromatography-tandem mass spectrometry and mRNA levels using
real-time PCR. Eicosanoid levels and transcriptomic data were combined using principal component analysis and hierarchical
clustering in order to associate metabolites with cell types. Samples were obtained from C57Bl/6 mice aged 16 weeks. We studied
the ob/ob genetically obese mouse model and diet-induced obesity model. We extended our results in mice to a cohort of
morbidly obese humans undergoing bariatric surgery.
RESULTS: Using our modelling approach, we determined that prostglandin D2 (PGD2) in adipose tissue was predominantly produced
in macrophages by the haematopoietic isoform of prostaglandin D synthase (H-Pgds). Analysis of sub-fractionated WAT conﬁrmed that
H-Pgds was expressed in adipose tissue macrophages (ATMs). Furthermore, H-Pgds expression in ATMs isolated from lean and obese
mice was consistent with it affecting macrophage polarisation. Functionally, we demonstrated that H-PGDS-produced PGD2 polarised
macrophages toward an M2, anti-inﬂammatory state. In line with a potential anti-inﬂammatory role, we found that H-PGDS expression
in ATMs was positively correlated with both peripheral insulin and adipose tissue insulin sensitivity in humans.
CONCLUSIONS: In this study, we have developed a method to determine the cellular source of metabolites within an organ and
used it to identify a new role for PGD2 in the control of ATM polarisation.
International Journal of Obesity advance online publication, 21 April 2015; doi:10.1038/ijo.2015.34
INTRODUCTION
As the world wide epidemic of obesity continues, a key question is
how obesity leads to metabolic complications, including diabetes
and cardiovascular disease. One proposed link between obesity,
insulin resistance, diabetes and cardiometabolic complications is the
concept that a loss of adipose tissue function leads to ectopic
deposition of lipids in other organs, which in turn causes insulin
resistance via the process of lipotoxicity.1 Understanding how obesity
leads to adipose tissue dysfunction is therefore essential in order to
design rational strategies for alleviating obesity-related metabolic
complication. One class of molecules that has attracted considerable
interest in the control of adipose tissue function are prostaglandins.
Prostaglandins, which are derived from 20-carbon length polyunsa-
turated fatty acids, have been suggested to link the consumption of
lipid-rich diets with adipose tissue dysfunction.
Although considerable research has focussed on the role of
prostaglandins within adipose tissue, the principal focus of these
studies has been on adipogenesis and adipocyte function,2–9
rather than the immune compartment. In terms of adipocyte
function, it is notable that many of the results observed for
prostaglandins in vitro have been poorly recapitulated in vivo. For
example, prostaglandin E2 (PGE2) has been demonstrated to
inhibit lipolysis in vitro via the PTGER3 receptor.4,6 In vivo, loss of
PGE2 signalling via the PTGER3 receptor has been reported to
cause lipodystrophy due to uninhibited lipolysis;10 however,
another report demonstrated that Ptger3 receptor KO mouse is
actually obese,11 casting doubt on the importance of lipolytic
regulation by this pathway in vivo.
In terms of eicosanoid levels in adipose tissue, several studies
have been published investigating the effect of ω-3 fatty acid
supplementation on lipid mediator levels in white adipose tissue
(WAT)12–14 as well as traditional dietary models of diet-induced
obesity using lard-rich diets14,15 and the genetically obese db/db
model.14 Intriguingly, in models of high-fat diet (HFD)-induced
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obesity, two-series prostaglandins were also reported to be
downregulated, despite the presence of large quantities of linoleic
acid (the precursor of arachidonic acid) being loaded into the
system, at least in the case of prolonged dietary treatments.14,15
The discrepancies between in vitro and in vivo effects of
prostaglandins on adipose tissue function can be in part explained
by the fact that many studies in vitro focus on adipocytes and
preadipocytes, while in vivo adipose tissue is made up of many
different cell types, which can both produce prostaglandins and
respond to these signalling molecules. One of the most important
cell types for mediating the metabolic phenotype of adipose
tissue in vivo are macrophages.
Obesity in both mice and humans is characterised by an
increase in both the number of macrophages and by a switch in
macrophage polarity from an anti-inﬂammatory (M2) to an
inﬂammatory (M1) state. Both inﬁltration of adipose tissue by
macrophages16 and their polarisation to an inﬂammatory state
have been shown to impact on whole organism insulin
sensitivity.17–20 In the past few years, multiple additional pathways
regulating adipose tissue macrophage (ATM) polarisation have
been investigated, implicating a diverse range of biological
processes, including traditional inﬂammatory signalling pathways
involving cytokines,20–22 cytokine signalling pathways,21–23,24
transcription factors involved in inﬂammatory signalling,25,26 fatty
acids27–30 as well as physiological interventions such as exercise.31
However, despite this research the signal that initiates macro-
phage polarisation in genetic and diet-induced obesity remains to
be fully elucidated.
Despite the growing body of evidence for the importance of
macrophages to the control of adipose tissue function, the role of
macrophages as a source of lipid mediators within adipose tissue
remains relatively unexplored. One of the major issues for
assessing the role of eicosanoids in speciﬁc cell types within any
tissue is that mechanical isolation of cells induces cellular stress,
almost certainly changing the endogenous levels of these
molecules. To avoid the problem of cellular isolation stress, in
this study we integrated prostaglandin levels from whole WAT
with mRNA markers of different cell types and biological processes
in a multivariate statistical model. Our model allowed the
assignment of prostaglandins to speciﬁc cellular compartments
within adipose tissue. Using this method, we investigated different
genetic and dietary states of obesity and demonstrate that
prostglandin D2 (PGD2) is predominantly produced by ATMs and
upregulated in obesity. Using bone marrow-derived macrophages
(BMDMs), we showed that haematopoietic isoform of prostaglan-
din D synthase (H-PGDS)-derived PGD2 acts during differentiation
to generate macrophages that exhibit an anti-inﬂammatory M2
phenotype. Of relevance, H-PGDS expression in human subcuta-
neous WAT (scWAT) macrophages was positively correlated with
both adipose tissue and peripheral insulin sensitivity.
MATERIALS AND METHODS
Animal care and diets
Mice were housed at a density of four animals per cage in a temperature-
controlled room (20–22 °C) with 12-h light/dark cycles. Wild-type (WT)
C57Bl/6 and ob/ob mice were purchased from Charles River (Harlow, UK).
Food and water were available ad libitum unless noted. All animal
protocols used in this study were approved by the UK Home Ofﬁce and the
University of Cambridge. Animals were fed on a normal chow diet (SDS
RM3 11.5% calories-from-fat) unless otherwise stated. HFD studies used
60% calories-from-fat diets (D12451 Research Diets, New Brunswick, NJ,
USA). Genders of mice are stated in the ﬁgure legends.
Eicosanoid extraction and quantiﬁcation
Extraction of eicosanoids was carried out as described previously20,32 with
the following modiﬁcations. Prior to the acidiﬁcation step and solid phase
extraction, WAT was ground on liquid nitrogen and then homogenised in
15% (v/v) methanol in water using a FastPrep-24 tissue homogeniser
(MP Biomedicals, Cambrigde, UK), followed by the addition of internal
standard PGB2-d4 (40 ng) (Cayman Chemicals, Ann Arbor, MI, USA).
Homogenates (1 ml) where transferred to a clean 2-ml Eppendorf tube
(Starlab, Milton Keynes, UK), and a further 1 ml of 15% (v/v) methanol in
water was added to the homogeniser tubes and the process repeated to
extract any remaining eicosanoids. This second 1ml was added to the
Eppendorf tubes, and the total homogenate was centrifuged at 16 000 g
for 5 min at 4 °C. The 'infranatant' between the lipid layer and the cellular
debris was removed and put in a 15-ml pyrex tube. A further 1 ml of 15%
(v/v) methanol in water was added to the remaining cellular debris in the
Eppendorf, vortexed and centrifuged at 16 000 r.p.m. for 5 min. For details
of the chromatography and mass spectrometry analyses, see
Supplementary Information.
Quantitative, real-time PCR and western blotting
See Supplementary Information for details.
Subcellular fractionation of adipose tissue
Adipocytes, macrophages and stromal vascular fraction were isolated by
collagenase digest followed by CD11b magnetism-activated cell sorter
(Miltenyi Biotech, Bisley, UK) separation (see Supplementary Information
for details).
BMDM culture
BMDMs were generated from murine hind-limb bone marrow and
differentiated in the presence of macrophage colony-stimulating factor
from L929 cells. BMDMs were treated during differentiation with 10 μM
HQL-79, 1 μM Ramatroban, a combination of 10 μM HQL-79 and 1 μM PGD2
or vehicle during differentiation. Macrophages were polarised using either
lipopolysaccharide (100 ng/ml) or interleukin-4 (10 ng/ml).
Human studies
Subcutaneous adipose tissue biopsies were collected from 17 individuals
undergoing bariatric bypass surgery. Macrophages were extracted as
described for mice (see Supplementary Methods). Prior to surgery, subjects
underwent a two-step hyper-insulinaemic euglycaemic clamp. For details
of the clamp subjects see de Weijer et al.,33 and for details of the clamp
conditions see Supplementary Information.
Statistics
Comparisons between mouse groups were carried out by one-way analysis
of variance followed by Tukey’s post-hoc test. For analysis comparing
expression levels in adipose tissue fractions, pairwise comparisons were
carried out within individual fractions. Pearson correlations were used for
regression data. All statistics were carried out using SPSS 21 (IBM, Armonk,
NY, USA). Principal component analysis (PCA) plots were generated using
SIMCA-P+ 12.0.1 (Umetrics, Umeå, Sweden). For details of NEATmap
generation, see Supplementary Information.
RESULTS
Prostaglandin levels in WAT
We used four separate mouse models to investigate the effects of
obesity on adipose tissue prostaglandin proﬁles, with all mice
culled at 16 weeks of age. Firstly, we used chow fed mice as a
control. Second, we used ob/ob mice fed a chow diet as a model
of extreme obesity without the effects of a change in diet. Finally,
we used two mouse models of HFD feeding, short-term HFD mice
were fed HFD from 12 to 16 weeks of age, whereas long-term HFD
mice were fed HFD from weaning (3 weeks) until 16 weeks of age.
The dietary conditions are shown in Figure 1a. As expected, the
ob/ob mice were much heavier than chow or high-fat-fed WT
mice and exhibited elevated blood glucose. Both the short-term
ang long-term high-fat fed mice showed modestly increased body
weight and increased blood-glucose levels compared with chow-
fed controls (Supplementary Figure S1).
Analysis of prostaglandin concentrations from WAT revealed
group-speciﬁc changes in PGE2 and PGD2. For abbreviations for
PGD2 and adipose tissue macrophage polarisation
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prostaglandins and their receptors see Supplementary Table S1.
PGE2 concentrations were reduced by high fat feeding, but not
changed in the ob/ob model relative to WT controls, whereas
PGD2 concentrations were increased in the ob/ob model
compared with the other groups (Figure 1b).
Expression of prostaglandin synthases and receptors
The mRNA expression levels of H-Pgds and Ptgis were regulated in
a manner that resembled their cognate metabolites. Conversely,
PGE2 metabolite concentrations were not similar to the expression
proﬁles of any PGE2 synthases (Figure 1c). We measured the
prostaglandin synthase Akr1b7,34–36 which has been shown to
regulate adiposity,37 but detected no signiﬁcant changes on a
whole tissue level. Equally, thromboxane synthase was
undetectable in adipose tissue and is likely to be expressed in
platelets and red blood cells, which lack mRNA.
The receptors for most of the prostaglandins showed only
limited regulation; however, the PGE2 receptor Ptger3 was found
to be downregulated in ob/ob mice on both an mRNA and protein
level (Figure 1d and Supplementary Figures S6A and B), whereas
the PGF2α receptor Ptgfr was found to be downregulated by both
dietary conditions and genetic obesity on an mRNA level
(Figure 1d) and by short-term HFD and in the ob/ob model on a
protein level (Supplementary Figures S6A and B).
Determining the cellular origin of cyclooxygenase metabolites
Adipose tissue is composed of multiple cell types. By using
multivariate statistical analysis, coupled with mRNA markers of
different cell types and biological processes, we attempted to assign
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Figure 1. Levels of eicosanoids in WAT. (a) Diagram representing the different dietary and genetic models of obesity used. (b) Levels of
cyclooxygenase products. (c) Expression levels of prostaglandin synthases. (d) Expression of prostaglandin receptors. (e) Representative
western blotting of H-PGDS. (f) Quantiﬁcation of H-PGDS protein in all samples normalised to β-actin. N= 8 mice per group, C57Bl/6 females,
16 weeks of age. Chow, 16-week-old mice fed a chow diet from weaning; ST HFD, mice fed a HFD from 12 to 16 weeks of age; LT HFD, mice fed
a HFD from weaning until 16 weeks of age; ob/ob, leptin-deﬁcient mice fed a chow diet from weaning until 16 weeks of age. *Po0.05.
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speciﬁc metabolites to cell types and functions. We selected genes
that are involved in several of the major biological processes that
occur in adipose tissue in which prostaglandins have been implicated,
including lipolysis4,6 (PGE2) and adipogenesis (PGI2 and PGF2α).
2,3,5,7,8
For a list of genes selected and their roles in speciﬁc processes in
adipose tissue see Supplementary Table S2. Furthermore, we chose
markers of preadipocytes, adipocytes, T-cells and macrophages,
representing many of the major cell types located within adipose
tissue that have clearly deﬁned, discrete mRNA markers.
We constructed a PCA model containing data from 32 mice and
including expression from 32 genes (Figure 1 and Supplementary
Figure S1). The model had a cumulative R2 score of 0.738
(Figure 2a). Although PCA is unsupervised, visual inspection of the
PCA plots suggested that the ﬁrst component (x axis) was driven
by insulin sensitivity and the second component (y axis) appeared
to be driven mainly by diet (Figure 2a).
The loading coefﬁcients for the PCA plot (Figure 2b) revealed that
markers of the same biological processes were closely related.
Macrophage markers were the strongest driver of the separation of
the ob/ob group (arrow 6). T-cell markers separated both the diet
and ob/ob groups (arrow 5). The strongest drivers toward the insulin-
sensitive chow group were Glut4 and Irs1 (arrow 3). The de novo
lipogenic programme was suppressed in the ob/ob group. However,
Scd1 was associated with mice fed a HFD, whereas Elovl6 and Fas
were suppressed by high-fat feeding (arrow 4). Overall, the data
demonstrated that the PCA model separated the animals based on
gene expression proﬁles that correspond to known phenotypic
changes associated with both the ob/ob model and high-fat feeding.
Prostaglandin synthases and metabolites associate with speciﬁc
biological processes
PGD2 was found to be closely associated with macrophage
markers, as was H-Pgds (Figure 2b). Conversely, Lipocalin
prostaglandin D synthase (L-Pgds), the other PGD2 synthase, was
not associated with PGD2 and is known to be a weak PGD
synthase,38 suggesting that it was not the source of PGD2 in
adipose tissue. 6-Keto-PGF1α (a surrogate for PGI2) and its synthase
Ptgis drove separation of the groups in the same direction as
Fabp4 and Pparγ2, in agreement with its known pro-adipogenic
role. PGF2 was found to be driving separation in the same
direction as Fas and Elovl6, two members of the lipogenic
programme. We also, in a separate analysis, measured endothelial
markers to determine whether any prostaglandins were asso-
ciated with the endothelium (Supplementary Figures S5B and C),
which suggested that the endothelium was not a major source of
prostaglandins within adipose tissue.
Although PGE2 levels were not found to have any positive
associations with biological processes studied, negative associa-
tions in PCA loading plots are found opposite to a given marker.
Hsl and Atgl were located nearly diametrically opposite PGE2 on
the loading plot, showing that PGE2 levels were negatively
associated with lipolytic markers (Supplementary Figure S2A).
Finally, PGE2 concentrations were negatively correlated pairwise
with the expression of Atgl and Hsl (Figure 2b).
Cluster analysis and circular heat map representation
To elucidate associations between metabolite concentrations and
gene expression data in more detail, we used a heat map approach
that combines hierarchical cluster analysis with a circular repre-
sentation of the proﬁles.39 Using this combined visualisation
approach, we detected that some metabolites and gene expression
proﬁles showed clear overlap with the phenotypic groups. On the
right hand side of the circular plot, we found proﬁles that showed a
distinct upregulation in the ob/ob group while being down-
regulated in all the other phenotypic groups. This second approach
again demonstrated the strong association between PGD2, H-Pgds
expression and the macrophage compartment (Figure 2c).
Expression of prostaglandin synthases in adipose tissue cellular
compartments
In order to substantiate the cell-speciﬁc origin of, and the
processes that metabolites were assigned to, we next investigated
the expression of prostaglandin synthases in macrophages
isolated from the adipose tissue of 5- and 16-week-old WT and
ob/ob mice. Ptgis was found to be predominantly expressed in the
stromal vascular fraction and signiﬁcantly downregulated in obese
mice at 16 weeks (Figure 3b), in line with the reduced rates of
adipogenesis in 16-week-old ob/ob mice. PGE synthases showed a
varied pattern of expression. At 5 weeks, Ptges1 and Ptges2 were
downregulated in the stromal vascular fraction in ob/ob mice
compared with WT. At 16 weeks, Ptges1 and 2 were down-
regulated in adipocytes and Ptges1 was downregulated in the
macrophages of ob/ob mice compared with controls.
Validation of PGD2 as a macrophage-derived eicosanoid
In line with its association with the macrophage compartment in
our multivariate statistical models, H-Pgds was found to be
expressed predominantly in the macrophage fraction (Figure 3b).
A second more comprehensive cellular isolation revealed that
H-Pgds was expressed in macrophages at a higher level than other
immune cells and was not expressed in the endothelial cells
(Supplementary Figure S5A). Although H-Pgds appeared to be
expressed in adipocytes isolated from 16-week-old ob/ob mice,
this apparent expression probably represented contamination
from macrophages, as Cd11c and F4/80 (Figure 3a) as well as many
other macrophage markers have been reported to be ‘expressed’
in adipocytes.40 Further, on a protein level, H-PGDS was only
detectable in ATMs in 16-week-old WT mice (Supplementary
Figure S3C). It was notable that H-Pgds was signiﬁcantly down-
regulated in ob/ob ATMs at 5 weeks and upregulated more than
twofold in ob/ob ATMs at 16 weeks. We have previously reported
a biphasic pattern of expression for multiple genes in macro-
phages from ob/ob mice, consistent with a switch from M2 to M1
polarisation.40 To further substantiate a role for H-Pgds in adipose
tissue function, H-Pgds expression was proﬁled in multiple
metabolic tissues. H-Pgds was expressed at higher levels in WAT
than in the brown adipose tissue, skeletal muscle, heart, liver or
kidney (Supplementary Figure S3A). Furthermore, we determined
that H-Pgds upregulation in response to HFD was macrophage-
speciﬁc by proﬁling ATMs isolated from mice fed a HFD for 1 or
6 months (Supplementary Figure S3B). Finally, H-Pgds was found
to be upregulated in the scWAT as well as the epididymal WAT of
ob/ob mice (Supplementary Figure S4A).
H-Pgds is upregulated during monocyte to macrophage
differentiation
It was striking that H-Pgds was regulated in a biphasic manner in
ATMs isolated from 5- and 16-week-old ob/ob mice compared
with WT. As mentioned above, we have previously detected this
phenotype for multiple markers of macrophage polarisation40 and
again conﬁrmed it in this study (Figure 3a). We next sought to
determine whether changes in PGD2 levels had functional
consequences in a BMDM cell model.
We detected that H-Pgds was upregulated (80-fold) during
differentiation from monocytes to macrophages on an mRNA level
(Figure 4a). However, treatment of monocytes with the H-PGDS
inhibitor HQL-79 during differentiation did not grossly inhibit
macrophage differentiation, with no differences in the expression of
the pan-macrophage marker F4/80 during differentiation (Figure 4a).
H-Pgds affects the terminal differentiation phenotype of
macrophages
In response to treatment with HQL-79, there were subtle but
signiﬁcant changes in the expression of polarisation markers.
PGD2 and adipose tissue macrophage polarisation
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Time courses for the M2 markers Cd36 and Arginase 1
revealed that inhibition of H-PGDS was associated with a
reduction in their expression (Figure 4a) on an mRNA level.
Conversely, the M1 markers Mcp1 and Tnfα were signiﬁcantly
upregulated by inhibition of H-PGDS with HQL-79. These results
suggested that endogenously produced PGD2 could polarise
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macrophages toward an M2 phenotype during differentiation
(Figure 4a).
PGD2 reverses the effects of inhibition of H-PGDS
To conﬁrm that effects of HQL-79 were due to inhibition of
H-PGDS, we sought to rescue inhibition of H-PGDS by adminis-
tering exogenous PGD2. Treating BMDMs with PGD2 and HQL-79
simultaneously reversed the effects of H-PGDS inhibition on the
expression of M1 markers (Figure 4b). Of the two PGD2 receptors,
only Crth2 was detectable in adipose tissue or BMDMs, suggesting
that effects of PGD2 were mediated via CRTH2 and not the DP1
receptor (Figure 4a). Overall, these results conﬁrmed a role for
PGD2 in the polarisation of macrophages toward an M2
phenotype.
Inhibition of H-PGDS during differentiation renders macrophages
more prone to M1 polarisation
Macrophages treated with HQL-79 during differentiation were
subsequently treated with interleukin-4 or lipopolysaccharide.
After 24 h, lipopolysaccharide induced the M1 polarisation
markers Tnfα, Il1b, Il6 and Cxcl1 to a greater degree in HQL-79-
treated cells than controls. Conversely, interleukin-4, which drives
polarisation of macrophages towards an M2 phenotype, caused a
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Figure 3. Expression proﬁles from sub-fractionated WAT. (a) Markers of macrophage abundance and polarisation. (b) Prostaglandin synthases
detectable in WAT and the Crth2 PGD2 receptor. N=45 groups for each age and genotype, C57Bl/6 male mice. *Po0.05.
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signiﬁcantly smaller induction in the levels of Arginase 1 and Ym1
in HQL-79-treated cells than in controls (Figures 5a and b).
Crth2 is downregulated in obese ATMs and mediates PGD2
signalling in vitro
At 16 weeks, ob/ob mice are profoundly obese and diabetic and
express large amounts of inﬂammatory markers in WAT. Therefore,
the ﬁnding that PGD2 appeared to render macrophages less
inﬂammatory appeared to contradict with the increased levels of
PGD2 and H-Pgds expression in 16-week-old ob/ob mice. However,
the PGD2-receptor Crth2 was downregulated sixfold in the ATMs
of ob/ob mice at 16 weeks (Figure 3b), compared with a
substantially smaller (twofold) induction in H-Pgds expression in
ATMs and a twofold induction of PGD2 concentrations in adipose
tissue. To conﬁrm a role for Crth2 in macrophage polarisation,
BMDMs were treated during differentiation with Ramatroban, a
CRTH2 inhibitor. Similar to the effects of HQL-79, Ramatroban
polarised macrophages towards a more M1 phenotype
(Supplementary Figure S4B).
H-PGDS expression in ATMs is positively correlated with peripheral
insulin sensitivity in humans
In line with the ﬁnding that PGD2 promotes an anti-inﬂammatory
M2-polarisation phenotype in macrophages, the expression of
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H-PGDS in macrophages isolated from human scWAT was
positively correlated with the rate of glucose disposal (Rd) in a
euglycaemic clamp in 17 morbidly obese individuals (Figure 5c).
Although Rd is considered a good marker of muscle insulin
sensitivity, its association with adipose tissue insulin sensitivity is
less clear. GLUT4 expression in adipose tissue has been shown to
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be well correlated with adipose tissue insulin sensitivity.41 In line with
this concept, we found that adipocyte GLUT4 expression correlated
with both Rd and H-PGDS expression in ATMs (Figures 5d and e).
DISCUSSION
In both dietary and genetic models of obesity, only PGD2 showed
substantial upregulation in obese adipose tissue. Furthermore, in
line with previous reports, PGE2 showed signiﬁcant downregula-
tion in dietary obesity14,15,42 but not in genetic obesity. Given the
known inﬂammatory changes that occur in adipose tissue in
response to dietary and genetic obesity22–25 as well as the deﬁned
roles for many prostaglandins in inﬂammation,43 it was surprising
that only PGD2 was associated with markers of inﬂammatory gene
expression. It was notable that the effects on PGD2 concentrations
and H-PGDS expression (Figures 1e and f) were much more
powerful in the ob/ob mouse model than in the HFD mice. This
was most likely because we used female mice, which are relatively
protected from the HFD (gaining only 4 g of weight relative to WT
controls); however, a role for leptin signalling cannot be excluded.
Although previous studies have investigated prostaglandin
levels in whole tissue, we sought to determine which cells were
producing given mediators in order to provide more information
about their potential roles within WAT. The most direct approach
would have been to measure lipid mediators in mechanically
separated cellular fractions. This approach has two major
limitations. First, a very large number of animals would be needed
to obtain sufﬁcient macrophages, adipocytes and stromal vascular
cells to measure eicosanoids. The second issue, however, was
more fundamental. Isolation of cells from adipose tissue by
collagenase digestion is known to induce considerable stress44
and almost certainly would alter the endogenous prostaglandin
proﬁles of the cells.
Although measuring eicosanoids from cellular fractions may
have provided information regarding the capacity for cells to
produce prostaglandins, it would not have provided information
about the endogenous levels of these molecules. To avoid
the issue of isolation-induced cellular stress, we applied a
mathematical-based approach. By combining the concentrations
of prostaglandins and the expression of mRNA markers from the
same tissue samples using a PCA model, we determined that PGD2
was associated with macrophage markers. PGI2 was shown to be
associated with markers of adipogenesis, a process in which it has
previously shown to be a positive regulator.2,3,28,29 Our analyses
also revealed that, while correlation does not imply causation,
PGE2 was negatively associated with lipolytic markers consistent
with its known antilipolytic role.4,5 Using a second multivariate
statistical analysis based on hierarchical clustering of metabolites
and transcriptional markers, we conﬁrmed a strong association
between PGD2 and the macrophage compartment. Using mRNA
samples from sub-fractionated WAT, we conﬁrmed that H-Pgds
was predominantly expressed in macrophages and regulated in a
manner consistent with a speciﬁc role in macrophage polarisation.
Although it is important to note that mRNA levels may not directly
equate to enzymatic activity, overall our approach provides a
valuable method to avoid stress-induced changes in short-lived
metabolite concentrations.
Given the expression proﬁle of H-Pgds, we hypothesised that
PGD2 would affect macrophage polarisation. As expected,
blocking endogenous PGD2 production with the inhibitor
HQL-79 affected polarisation; however, it appeared that PGD2
was responsible for driving macrophages toward an M2 pheno-
type. The increased concentrations of PGD2 in adipose tissue and
the elevated H-Pgds expression in 16-week-old ob/ob macro-
phages seemed inconsistent with an anti-inﬂammatory role for
PGD2. However, the PGD2 receptor Crth2 was much more potently
downregulated in macrophages than H-Pgds was upregulated,
suggesting that PGD2 signalling may be compromised in obese,
insulin-resistant states. Furthermore, inhibiting CRTH2 in BMDMs
polarised them towards a more M1 phenotype. Finally, our results
suggesting a protective role for H-Pgds on macrophage polarisa-
tion were further supported by the fact mice transgenically
overexpressing H-Pgds are more insulin sensitive.45
Finally, to investigate a potential role for H-PGDS in human
macrophage function, we used ATMs isolated from human scWAT.
We found that H-PGDS mRNA levels correlated with both GLUT4
expression in adipocytes (a marker of adipose tissue insulin
sensitivity) and peripheral insulin sensitivity. Although our results
are promising, further investigation into the role of H-PGDS in
human adipose tissue will be required. Expression of M2 markers
in human subcutaneous ATMs have previously been shown to
correlate with insulin sensitivity in a similar manner.46
As part of our study, we attempted to separate the loading of
substrates for eicosanoid biosynthesis, which are present at high
levels in HFD, from the effects of high-fat feeding on insulin
sensitivity by using a short- and long-term high-fat feeding
protocols. Surprisingly, we found almost no differences on either
the metabolite or mRNA expression level between the two
paradigms. This suggests that, at least for adipose tissue, feeding
HFD from weaning until 16 weeks of age (13 weeks of HFD) has a
similar effect to feeding HFD from 12 weeks to 16 weeks of age
(4 weeks of HFD).
Overall, our study provides solid evidence for H-Pgds having a
role in the control of ATM polarisation and obesity-associated
adipose tissue dysfunction and suggests that modulation of the
H-Pgds signalling pathway in macrophages may, in future, be a
promising approach for the treatment of insulin resistance and
diabetes. To obtain these conclusions, it has been necessary to
develop a new technique to allow the assignation of the origin of
metabolites to speciﬁc cell types within tissues without the need
to isolate individual cells. This method has multiple potential
applications for the study of tissues where isolation and proﬁling
of cellular fractions is either impossible or in states where the
isolation procedure itself will cause unwanted alterations in
metabolite levels.
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